Open access · CC-BY
via OpenAlex
Resveratrol and SIRT1 Activators for the Treatment of Aging and Age-Related Diseases
Alessandra Stacchiotti, Gaia Favero, Rita Rezzani
IntechOpen eBooks · 2019 · ▲ 14 citations
Genomic instability
Epigenetic alterations
Deregulated nutrient-sensing
Intermittent fasting
Human
Preclinical / animal
Abstract
Reduced calorie intake is a religious and medical practice known since very old times, but its direct influence on life span in all organisms, included humans, has been demonstrated in the modern era. Not only periodic fasting, but also natural or synthetic compounds that mimic this phenomenon are growing to slow aging and the onset of chronic morbidities. Resveratrol (RSV), a plant polyphenol, is an elixir of longevity for simple organisms and preclinical rodent models even if a beneficial role in humans is still debated. Its main rejuvenating mechanism copes with the activation of specific longevity genes called sirtuins. Among seven known mammalian sirtuins, sirtuin 1 is the most studied. This pleiotropic nicotinamide adenine dinucleotide (NAD)-based deacetylase maintains longevity by removing acetyl group in nuclear histones, transcription factors, and other DNA repairing proteins. Actually, an exciting challenge is to discover and test novel sirtuin 1 activators to extend life span and to treat age-associated disabilities. This chapter updates on the antiaging effect of RSV and sirtuin 1 activators in experimental animals and in humans. Finally, pros and cons on RSV analogues and sirtuin 1 activators tested in preclinical and clinical trials to hamper neurological deficit, cardiovascular complications, diabetes, bone and muscle deterioration, and cancer are discussed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5772/intechopen.78977
- Canonical
- link ↗
- Fetched
- 2026-06-22 MST
Cite this
APA
Stacchiotti, A., Favero, G., & Rezzani, R. (2019). Resveratrol and SIRT1 Activators for the Treatment of Aging and Age-Related Diseases. <em>IntechOpen eBooks</em>. https://doi.org/10.5772/intechopen.78977
Vancouver
Stacchiotti A, Favero G, Rezzani R. Resveratrol and SIRT1 Activators for the Treatment of Aging and Age-Related Diseases. IntechOpen eBooks. 2019. doi:10.5772/intechopen.78977.
BibTeX
@article{alessandra2019Resver,
title = {Resveratrol and SIRT1 Activators for the Treatment of Aging and Age-Related Diseases},
author = {Alessandra Stacchiotti and Gaia Favero and Rita Rezzani},
journal = {IntechOpen eBooks},
year = {2019},
doi = {10.5772/intechopen.78977},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2024
Preprint
Sirtuin 1 and Hormonal Regulations in Aging
Journal of the American Association of Nurse Practitioners 2021
Citation only
Genomics of aging: The role of sirtuin and metabolic health
University of Genova 2020
Open access · US-GOV
Phase I/II Randomized Clinical Study of Cycles of a New Formulated FMD in Prefrail Elderly.
Postępy Higieny i Medycyny Doświadczalnej 2024
Open access · CC-BY
Factors of the aging process and longevity—selected data
Inna Chen, MD 2026
Open access · US-GOV
A Multicentre, Parallel-group, Open-label, Two-arm Randomised Trial of Personalised Nutritional Care Compared With Usual Nutritional Care in Patients Aged 65 Years or Older With Pancreatic Ductal Adenocarcinoma
Elsevier eBooks 2019
Citation only